NEUP vs SHW · rev $15.7M vs P/E 29, rev $12.46B
Neuphoria Therapeutics Inc (NEUP) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
NEUP currently screens at market cap $23.6M. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the NEUP and SHW stock pages for the full models.
Not investment advice.